Legal Affairs

Germany Boosts Medical Cannabis Import Cap

BERLIN – German health authorities have increased the annual limit on medical Cannabis imports to 192.5 metric tons, in an effort to keep up with the rapid growth in patient demand while the country navigates ...

Compass Pathways Advances Psilocybin Research in the UK

LOS ANGELES- Compass Pathways, a biotechnology company specializing in mental health innovations, has commenced the UK segment of its global Phase 3 clinical trial evaluating COMP360 psilocybin therapy for treatment-resistant depression (TRD). This initiative follows ...

Ohio’s Cannabis Market Expansion in 2024

LOS ANGELES- In 2024, Ohio's legal cannabis market achieved sales exceeding $675 million, marking a 40% increase from the previous year's $484 million. This growth is attributed to the commencement of adult-use cannabis sales in ...

Kentucky Implements Medical Cannabis Program

LOS ANGELES- As of January 1, 2025, Kentucky has officially implemented its medical cannabis program, allowing residents with qualifying medical conditions to access cannabis for therapeutic purposes. This development follows the enactment of Senate Bill ...

DEA Postpones Cannabis Rescheduling Hearing to 2025

LOS ANGELES- The Drug Enforcement Administration (DEA) has postponed its public hearing on the proposed rescheduling of cannabis under federal law. Initially scheduled for December 2, 2024, the hearing is now expected to occur in ...

What You Need to Know About Cash Flow Management

NEW YORK- Every CFO and entrepreneur in Cannabis and Psychedelics needs to know that efficient cash flow management is essential in the cannabis industry, where companies face specific financial challenges. WELCOME Back to this fresh ...

Cansortium Completes Merger with RIV Capital

LOS ANGELES- Cansortium Inc., operating under the Fluent brand, has finalized its merger with RIV Capital Inc., establishing a multi-state cannabis operator with a presence in Florida, New York, Texas, and Pennsylvania. The merger results ...

Psyence Biomed Completes $2 Million Private Placement

LOS ANGELES- Psyence Biomedical Ltd. , a biotechnology firm specializing in psilocybin-based psychedelic medicines, has finalized a private placement, securing approximately $2 million in gross proceeds. The financing involved the issuance of 1,000,000 common shares ...

Subscribe To Our Newsletter